Shoulder Innovations (SI) Stock Price, News & Analysis

Company Overview

Shoulder Innovations, Inc. (NYSE: SI) is a medical device company dedicated to the design, development and commercialization of implant solutions for shoulder reconstruction and fixation procedures. The company’s product portfolio encompasses both anatomic and reverse total shoulder replacement systems, as well as trauma fixation devices, all of which are engineered to address a wide range of shoulder pathologies and surgical approaches.

Key offerings include an anatomic shoulder system designed to mimic native joint biomechanics, and a reverse shoulder system offering enhanced stability and function in cases of rotator cuff insufficiency. In addition to implant components, the company provides sterile-packed instrumentation and intramedullary fixation nails that support minimally invasive and conventional surgical techniques. Continuous research and development initiatives focus on advancing implant materials, optimizing instrumentation ergonomics and refining surgical protocols to improve patient outcomes and operating room efficiency.

Founded in 2003 and based in Salt Lake City, Utah, Shoulder Innovations markets its products throughout the United States and has established distribution partnerships in selected international markets. The company’s leadership team brings together experienced professionals from orthopaedics, biomedical engineering and commercial operations, driving strategic growth, regulatory compliance and clinical education efforts. Through surgeon training programs and peer-reviewed clinical studies, Shoulder Innovations seeks to validate its technologies and expand its presence within the global shoulder arthroplasty market.

Key Stats

• Today's Range: $14.82 to $15.80
• 50-Day Range: N/A
• 52-Week Range: $11.75 to $17.94
• Volume: 91,140 shs
• Average Volume: 176,639 shs
• Market Capitalization: $227.23 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: $19.60
• Consensus Rating: Moderate Buy

Shoulder Innovations Stock Analysis - MarketRank™

Shoulder Innovations scored higher than 65% of companies evaluated by MarketBeat, and ranked 354th out of 940 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 4.4 / 5
• Analyst Rating: Moderate Buy

Consensus Rating

Shoulder Innovations has received a consensus rating of Moderate Buy. The company's average rating score is 2.83, and is based on 5 buy ratings, 1 hold rating, and no sell ratings.

Amount of Analyst Coverage

Shoulder Innovations has been the subject of 6 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

Earnings and Valuation

• Score: 0.6 / 5
• Proj. Earnings Growth: Growing

Earnings Growth

Earnings for Shoulder Innovations are expected to grow in the coming year, from ($0.56) to ($0.35) per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Shoulder Innovations is -0.50, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of Shoulder Innovations is -0.50, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Short Interest

• Score: N/A
• Short Interest Level: N/A

Short Interest

There is no current short interest data available for SI.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Shoulder Innovations does not currently pay a dividend.

Dividend Growth

Shoulder Innovations does not have a long track record of dividend growth.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Short Interest

There is no current short interest data available for SI.

News and Social Media

• Score: 3.0 / 5
• News Sentiment: 0.40

News Sentiment

Shoulder Innovations has a news sentiment score of 0.40. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 1.11 average news sentiment score of Medical companies.

News Coverage This Week

MarketBeat has tracked 13 news articles for Shoulder Innovations this week, compared to 1 article on an average week.

Search Interest

7 people have searched for SI on MarketBeat in the last 30 days.

MarketBeat Follows

3 people have added Shoulder Innovations to their MarketBeat watchlist in the last 30 days. This is an increase of 200% compared to the previous 30 days.

Company Ownership

• Score: 1.7 / 5
• Insider Trading: Acquiring Shares

Insider Buying vs. Insider Selling

In the past three months, Shoulder Innovations insiders have bought more of their company's stock than they have sold. Specifically, they have bought $11,675,730.00 in company stock and sold $0.00 in company stock.

SI Stock Analysis - Frequently Asked Questions

How have SI shares performed this year?

Shoulder Innovations' stock was trading at $15.09 on January 1st, 2025. Since then, SI shares have decreased by 1.1% and is now trading at $14.92.

How were Shoulder Innovations' earnings last quarter?

Shoulder Innovations, Inc. (NYSE:SI) announced its quarterly earnings data on Monday, October, 18th. The company reported $0.88 earnings per share for the quarter, topping the consensus estimate of $0.71 by $0.17. The business had revenue of $51.71 million for the quarter, compared to analyst estimates of $45.19 million.

Does Shoulder Innovations have any subsidiaries?

Shoulder Innovations subsidiaries include these companies: Silvergate Bank, Silvergate Capital Trust I, Silvergate Capital Trust II, and Spring Valley Lots.

When did Shoulder Innovations IPO?

Shoulder Innovations (SI) raised $75 million in an initial public offering on Thursday, July 31st 2025. The company issued 5,000,000 shares at $15.00 per share.

When does Shoulder Innovations' quiet period expire?

Shoulder Innovations's quiet period expires on Tuesday, September 9th. Shoulder Innovations had issued 5,000,000 shares in its initial public offering on July 31st. The total size of the offering was $75,000,000 based on an initial share price of $15.00. During Shoulder Innovations' quiet period, underwriters and any insiders that worked on the IPO are restricted from issuing any research reports or earnings estimates for the company because of regulations issued by the Securities and Exchange Commission. Following the end of the company's quiet period, the brokerages that served as underwriters will likely initiate research coverage on the company.

How do I buy shares of Shoulder Innovations?

Shares of SI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Shoulder Innovations own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Shoulder Innovations investors own include NVIDIA (NVDA), Meta Platforms (META), Tesla (TSLA), Advanced Micro Devices (AMD), PayPal (PYPL), Alibaba Group (BABA).

Company Calendar

• Last Earnings: 10/18/2021
• Today: 9/02/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NYSE
• Sector: Medical
• Industry: Surgical, Medical, And Dental Instruments And Supplies
• Sub-Industry: Medical Equipment
• Current Symbol: NYSE:SI
• Previous Symbol: NYSE:SI
• CIK: 1699350
• Web: N/A
• Phone: 616-566-0286
• Fax: N/A
• Employees: 61
• Year Founded: 1988

Price Target and Rating

• Average Price Target for Shoulder Innovations: $19.60
• High Price Target: $23.00
• Low Price Target: $18.00
• Potential Upside/Downside: +31.4%
• Consensus Rating: Moderate Buy
• Rating Score (0-4): 2.83
• Research Coverage: 6 Analysts

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 15,230,000
• Free Float: N/A
• Market Cap: $227.23 million
• Optionable: No Data
• Beta: N/A